Mark L. Lee

Effect of platelet activating factor on endothelial permeability to plasma macromolecules

Dean A. Handley, Cynthia Arbeeny, Mark L. Lee et al. · Immunopharmacology · 1984 · 78 citations

Inflammation, Thrombosis, Endothelial Permeability +15

Platelet activating factor-induced ischemic bowel necrosis: The effect of PAF antagonists

Wei Hsueh, F. González‐Crussi, Josepha L. Arroyave et al. · European Journal of Pharmacology · 1986 · 61 citations

Inflammation, Thrombosis, Thrombopoiesis +12

Inhibition and reversal of endotoxin-, aggregated IgG- and paf-induced hypotension in the rat by SRI 63-072, a paf receptor antagonist

Dean A. Handley, Ronald G. Van Valen, Mary Kay Melden et al. · Immunopharmacology · 1986 · 48 citations

Signal Transduction, Medicine, Physiology +9

Antitumor activity of SRI 62‐834, a cyclic ether analog of ET‐18‐OCH₃

William J. Houlihan, Mark L. Lee, P. G. Munder et al. · Lipids · 1987 · 44 citations

Evidence for a Direct Effect on Vascular Permeability of Platelet-Activating Factor Induced Hemoconcentration in the Guinea Pig

Dean A. Handley, Mark L. Lee, Robert N. Saunders · Thrombosis and Haemostasis · 1985 · 26 citations

Pharmacotherapy, Inflammation, Thrombosis +20